Introduction: Overweight and obesity in childhood and adolescence are important public health problems. In this context, the school has been identified as a favorable environment for carrying out health education programs. The Health at School Program and its important performance stand out. Thus, considering these discussions, they ask: How are the actions developed by the Health at School Program, focused on nutrition, being implemented?
Objective: Analyze the teenager monitoring in the School Health Program (PSE in Brazil) opposite actions to the nutritional aspects of adolescents.
Methods: This is a descriptive, qualitative study in Juazeiro municipality North-Ce, with the subject 18 nurses of the Family Health Strategy (FHS) inserted in the PES that municipality.
Results: Nurses have limited assistance in the face of food practices, which implies in its operations; report having difficulty performing their actions outside the conventional health units and focus on strategies for a food menu.
Conclusion: The monitoring of adolescents in the School Health Program ahead nutritional value is still limited to preventive practices involving specific actions, limited to a Sfood education focused on the health problem and not the needs of adolescents.
Intestinal mucositis is a frequent complication in the treatment of cancer with the chemotherapeutic agent 5‐fluorouracil (5‐FU). So far there is still no effective treatment of this condition. Cashew gum (CG) has been reported as a potent anti‐inflammatory. The present study aimed to evaluate the effect of Cashew gum (Anacardium occidentale L.) on 5‐fluorouracil‐induced intestinal mucositis in Swiss mice. The mice (25–30g) were secreted into 5 groups (n = 6): Saline group (NaCl 0.9%), 5‐FU group, CG group (90mg/kg CG, vo), CLX group (Celecoxib ip), CLX + CG group (Celecoxib ip, 90mg/kg GC). All animals except Saline group received 5‐FU at the concentration of 450mg/kg in the first experimental protocol. Duodenal portions were removed for evaluation of mucositis by histopathological and immunohistochemical analysis for cyclooxygenase‐2 (COX‐2). The results of the histopathological analysis demonstrated that 5‐FU promoted structural alterations of the intestinal mucosa, evidenced by the reduction of villi height, deepening of the crypts, and intense inflammatory infiltrate, in comparison to the Salina group, characterized by the integrity of the villi and crypts and absence of inflammatory infiltrate. CG animals showed a significant reversal of the effects promoted by antineoplastic in the villi, crypts and inflammatory cells infiltration in comparison to the 5‐FU group. CLX group, as well as CLX + GC, were able to significantly prevent (p <0.05) destruction of crypts, shortening of villi with cellular vacuolization, and inflammatory infiltrate. Regarding the immunoblotting for expression of COX‐2, it can be observed that the saline group showed subtle immunostaining when compared to the 5‐FU group (p <0.05), in which intense and generalized immunostaining was observed. In the CG, CLX and CLX + CG groups, there was a decrease in the immunostaining when compared to the 5‐FU lesion group. In addition, the amount of COX‐2‐immunolabelled cells in the CLX + CG group was lower than the CG treated group. It is concluded that CG prevented the intestinal mucosa promoted by the 5‐FU antineoplastic, in addition to decreasing the expression of the COX‐2 enzyme, an important element in the onset and exacerbation of inflammation.Support or Funding InformationThis study received funding of CNPQ and CAPESThis abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.